Paying for Mounjaro with Clearpay: what the rules actually mean

You've found the Clearpay option, here's why it doesn't appear on legitimate pharmacy sites

Picture this: you've looked at the monthly cost of Mounjaro, worked out it adds up to a meaningful sum, and reached for the instalment option the way you would with a new laptop or a pair of trainers. It makes intuitive sense. But prescription medicines sit in a separate legal category from retail goods, and that changes everything about how they can be sold.

In the UK, Mounjaro is regulated under the Human Medicines Regulations 2012 as a Prescription-Only Medicine. A GPhC-registered pharmacy can only dispense it after a prescriber has assessed you and issued a valid prescription. Buy-now-pay-later platforms (Clearpay included) explicitly exclude prescription medicines and healthcare services from their terms; if you're researching Mounjaro and Clearpay, it's important to understand that the transaction simply cannot complete in the normal way. This isn't a pharmacy-by-pharmacy policy choice. It applies across the board.

If you do find a site offering Mounjaro through Clearpay, that should stop you. The MHRA has warned publicly that fake and illegally traded weight-loss pens are circulating online, and reading what people who searched for Mounjaro via Clearpay have reported makes clear that sellers willing to sidestep the prescription process are precisely the ones selling medicines that may be counterfeit or incorrectly stored. The MHRA's Drug Safety Update communications document the risks in detail, including hospitalisations linked to fake pens. No saving on a monthly instalment is worth that.

There's more context about how Mounjaro is priced in the UK on our Mounjaro cost overview, which explains what a typical legitimate price covers and why the figures vary between providers.

Why the cost feels high, and what a legitimate price actually includes

With Mounjaro prices rising significantly from 1 September 2025, when Eli Lilly revised the UK list price for the higher doses, the highest dose now carries a list price of around £330 per four-week pen; typical private prices across providers range roughly £149–£375 per month depending on dose, according to widely reported figures at the time of Lilly's announcement. That's a substantial monthly commitment, and it's reasonable to look for ways to manage it.

What's worth understanding is what a legitimate price at a GPhC-registered pharmacy actually covers. At a properly run online pharmacy, the cost should include the clinical consultation, the prescription itself, the medicine, and tracked delivery. At nume, there are no separate consultation or prescription fees, and next-working-day delivery by DPD is included, your pen arrives in plain, unbranded packaging, with a tracking link so you know exactly when to expect it. No subscription, no auto-renewal. Each repeat order is reviewed by a prescriber before it goes out.

The breakdown of what goes into Mounjaro pricing is worth reading if you're comparing providers. Some of the lower headline figures you'll see don't include the prescription fee, consultation charge, or delivery, add those back in and the difference can narrow considerably.

What to do instead if the monthly cost is a stretch

The honest answer is that there is no legally compliant instalment scheme for prescription weight-loss medicines in the UK right now. If you're wondering where to buy Mounjaro with Clearpay, the answer is that no legitimate pharmacy can offer this, and that may change as the market matures, but at the time of writing it isn't available from legitimate providers.

What you can do is think about the cost per week rather than per month. At mid-range doses, many people find the monthly figure sits somewhere between a gym membership and a weekly food-shop top-up, not trivial, but more manageable when framed as a daily or weekly figure. It's also worth knowing that treatment isn't necessarily lifelong: many people use it for a defined period to establish new habits alongside the appetite changes the medicine brings.

If you're weighing up whether private treatment makes sense for your situation, the starting point is a clinical assessment. A prescriber can confirm whether you meet the eligibility criteria (broadly, a BMI of 30 or above, or 27 or above with a relevant health condition) and talk through what the treatment journey looks like. The NHS route exists too; our overview of weight-loss treatment options covers how the NHS phased rollout works and where private treatment fits alongside it.

Mounjaro is a prescription medicine assessed by a qualified clinician, as the NHS tirzepatide information page makes clear. NICE's appraisal (TA1026) sets out the clinical evidence base. The prescriber's job is to weigh all of that against your individual history, that's not a formality, it's what keeps the treatment safe and appropriate.

If you have questions about eligibility or want to understand what's involved before committing, checking your eligibility with our clinical team costs nothing and takes a few minutes.